LM Pay

LM Pay EBIT Growth

The Year-over-Year EBIT Growth of LM Pay (Y00.BE) as of Nov 4, 2026 is -94.76 %. In the previous year, Year-over-Year EBIT Growth was -63.87 % — a change of 48.37% (lower).

EBIT Growth

-94.76 %

YoY

48.37%

Last updated:

Year-over-Year EBIT Growth of LM Pay is 2023 -94.76 % . Year-over-Year EBIT Growth of LM Pay was 2022 -63.87 % . It decreases by 48.37% lower compared to the previous year.

The LM Pay EBIT Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Growth
Date
EBIT Growth
Jan 1, 2022
-63.87 PLN
Jan 1, 2023
-94.76 PLN
The LM Pay EBIT Growth history
YEAREBIT GrowthYoY
-94.76 %+48.37%
-63.87 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

LM Pay Stock analysis

What does LM Pay do? LM Pay SA generates revenue through its MediRaty financing and installment payment system, which targets consumers seeking medical and veterinary services. The company partners with clinics offering specialized treatments like dentistry, plastic surgery, and orthopedics, enabling patients to finance procedures such as dental implants, liposuction, and breast augmentation through MediRaty or MediPay programs. These services are available at both partner facilities and non-partner locations, with financing options tailored to cover costs in fields including ophthalmology, gynecology, and veterinary care. The firm monetizes by facilitating installment payments for medical and veterinary expenses without direct ownership of the services provided. The primary customers are individuals requiring medical treatments or veterinary services, with the company focusing on high-cost procedures such as orthodontic braces, implant prosthetics, and aesthetic surgeries. LM Pay SA’s revenue model relies on transaction fees from clinics and service providers that utilize its financing platforms, rather than direct consumer payments. This approach allows the company to serve a broad segment of consumers seeking accessible financing for healthcare without bearing the risk of the medical services themselves. MediRaty and MediPay programs are designed to integrate seamlessly with clinics' operations, providing patients with flexible payment options. The company’s revenue streams are derived from the financial institutions or healthcare providers that adopt its systems, as these partners pay for access to the financing infrastructure. This business model ensures consistent income from established healthcare and veterinary service providers across Poland, supporting the expansion of affordable healthcare financing options for end-users. LM Pay is one of the most popular companies on Eulerpool.

Frequently Asked Questions about LM Pay stock

Year-over-Year EBIT Growth of LM Pay is -94.76 % in 2023.

On Eulerpool you can find the complete historical development of Year-over-Year EBIT Growth LM Pay since 2006 – with annual values, charts, and detailed analysis.

EBIT growth measures the percentage change in operating earnings. It shows whether a company's core operations are becoming more profitable.

To evaluate Year-over-Year EBIT Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBIT Growth.

Year-over-Year EBIT Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBIT Growth's LM Pay historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — LM Pay

All Key Metrics — LM Pay